MLSS · Milestone Scientific Inc. · Financials
$0.44
+0.01 (+2.28%)
At close · Sep 11
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“The Company has incurred recurring operating losses and has an accumulated deficit. These conditions raise substantial doubt about the Company's ability to continue as a going concern. ... Management believes that existing cash resources, anticipated collections and potential financing proceeds may support near-term operations; however, additional financing is required, and there can be no assurance that such financing will be available on acceptable terms, or at all. Accordingly, substantial doubt about the Company's ability to continue as a going concern has not been alleviated.”View the 10-Q filed Aug 13, 2026
Market Cap
$39.40M
Shares
88.74M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$8.97M
+4%
FY2025
Net Income
-$5.72M
-21.4%
FY2025
Gross Margin
71.4%
-3.2pp
FY2025
Operating Margin
-63.48%
+14.8pp
FY2025
Diluted EPS
-$0.07
-16.7%
FY2025
Operating Cash Flow
-$2.92M
+0.1%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $9.8M – $10.2M | $9.42M | $8.97M | $8.63M | $9.83M | $8.81M | $10.3M | $5.44M | $8.37M | $9.62M | $11.28M | — | — | — | — | — | — | — | |
| — | $19.55K | — | $60.27K | $125.53K | $54.61K | -$16.36K | -$18.08K | $1543 | $7447 | — | — | — | — | — | — | — | — | |
| — | $2.8M | $2.57M | $2.2M | $3.03M | $3.91M | $3.99M | $1.82M | $2.66M | $5.19M | $4.31M | $4.18M | $3.05M | $3.63M | $3.2M | $3.06M | $3.02M | $3.53M | |
| — | $6.62M | $6.41M | $6.43M | $6.79M | $4.9M | $6.31M | $3.62M | $5.72M | $4.43M | $6.97M | $6.31M | $6.44M | $6.7M | $6.81M | $5.59M | $5.36M | $6.22M | |
| — | — | 71.4% | 74.56% | 69.12% | 55.65% | 61.25% | 66.6% | 68.28% | 46.05% | 61.77% | — | — | — | — | — | — | — | |
| — | — | $449.47K | $858.77K | $701.38K | $1.15M | $878.21K | $307.85K | $189.92K | $245.64K | $272.75K | $1.27M | $100.86K | $88.24K | $191.35K | $181.98K | $140.05K | $270.49K | |
| — | $10.61M | $11.58M | $12.3M | $13.14M | $12.51M | $12.74M | $10.67M | $9.53M | $10.65M | $11.93M | $11.55M | $9.4M | $7.4M | $5.53M | $5.93M | $6.45M | $6.65M | |
| — | $68.64K | $69.34K | $30.23K | $49.32K | $49.66K | $51.63K | $53.01K | $53.01K | $814.68K | $510.68K | $70.7K | $69.43K | $78.46K | $77.95K | $76.32K | $83.3K | $83.4K | |
| — | $78.3K | $78.2K | $37.45K | $61.91K | $63.76K | $73.84K | $95.95K | $100.51K | $881.29K | $573.15K | — | — | — | — | — | — | — | |
| — | $10.72M | $12.1M | $13.19M | $13.9M | $13.73M | $13.69M | $11.07M | $9.72M | $12.43M | $12.2M | $12.82M | $9.5M | $7.49M | $5.73M | $6.11M | $6.59M | $6.92M | |
| — | -$4.1M | -$5.7M | -$6.76M | -$7.11M | -$8.83M | -$7.38M | -$7.45M | -$4M | -$8M | -$5.23M | -$6.51M | -$3.06M | -$790.18K | $1.09M | -$520.35K | -$1.22M | -$700.84K | |
| — | — | -63.48% | -78.3% | -72.31% | -100.24% | -71.6% | -137.08% | -47.75% | -83.14% | -46.4% | — | — | — | — | — | — | — | |
| — | -$4.03M | -$5.62M | -$6.72M | -$7.04M | -$8.76M | -$7.3M | -$7.36M | -$3.9M | -$7.12M | -$4.66M | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | — | — | — | — | $2668 | $70.8K | $175.91K | $131.84K | $95.14K | |
| — | — | — | — | — | — | — | — | — | $7447 | $9298 | $1285 | $3838 | $2389 | $115 | $34 | $35 | $587 | |
| — | — | — | — | — | — | — | -$24.79K | -$10.41K | -$7232 | -$4930 | -$5088 | -$1509 | $2389 | $378.23K | — | — | $183.67K | |
| — | — | — | — | — | $0 | $242.59K | $97.89K | $81.32K | $329.7K | -$120.51K | -$795.83K | -$2.45M | -$910.2K | -$924.36K | -$171.02K | -$121.4K | — | |
| — | -$4.14M | -$5.72M | -$4.71M | -$6.98M | -$8.77M | -$7.12M | -$7.47M | -$7.64M | -$8M | -$5.23M | -$6.52M | -$3.06M | -$1.7M | $1.46M | — | — | — | |
| — | — | — | — | $0 | $0 | $333 | $15.5K | $18.13K | $23.99K | $19.09K | -$19.1K | $36.16K | $9509 | — | — | — | — | |
| — | -$4.14M | -$5.72M | -$4.71M | -$6.93M | -$8.71M | -$6.82M | -$7.34M | -$7.52M | -$7.43M | -$5.19M | -$5.95M | -$5.47M | -$1.7M | $1.46M | -$870.31K | -$1.48M | -$614.51K | |
| — | — | -63.76% | -54.62% | -70.51% | -98.87% | -66.17% | -134.94% | -89.85% | -77.24% | -45.97% | — | — | — | — | — | — | — | |
| — | — | — | $0 | -$51.84K | -$66.74K | -$58.12K | -$51.54K | -$55.87K | -$260.13K | -$182.76K | -$1.35M | -$72.38K | -$5472 | — | — | — | — | |
| USD/shares | — | -$0.05 | -$0.07 | -$0.06 | -$0.10 | -$0.12 | -$0.10 | -$0.12 | -$0.16 | -$0.21 | -$0.16 | -$0.22 | -$0.26 | -$0.08 | $0.09 | -$0.05 | — | — |
| USD/shares | — | -$0.05 | -$0.07 | -$0.06 | — | — | -$0.10 | -$0.12 | -$0.16 | -$0.21 | -$0.16 | -$0.22 | -$0.26 | -$0.08 | $0.08 | -$0.05 | — | — |
| shares | — | — | 82.06M | 79.79M | 72.78M | 70.61M | 68.83M | 63.06M | 45.74M | 35.3M | 32.7M | 26.97M | 21.43M | 20.06M | 17.13M | 16.08M | 15.17M | — |
| shares | — | — | 82.06M | 79.79M | — | — | 68.83M | 63.06M | 45.74M | 35.3M | 32.7M | 26.97M | 21.43M | 20.06M | 17.48M | 16.08M | 15.17M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Peer median 1.49×
EV/EBIT
—
Peer median 14.69×
P/E (TTM)
—
Peer median 18.24×
Peer medians compare against the 15 similar-size Medical Instruments & Supplies companies (of 46 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dental | $8,790,732 | $8,525,308 | — | — | — | — |
| Medical | $183,250 | $104,620 | — | — | — | — |
| Dental Segment | — | — | $9,761,444 | $8,753,156 | $10,152,511 | $5,421,436 |
| Medical Segment | — | — | $66,000 | $52,750 | $152,200 | $15,800 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| United States | $4,969,215 | $5,254,331 | — | — | — | — |
| Rest of World | $3,694,767 | $3,375,597 | $4,195,564 | $4,886,070 | $4,635,034 | $3,239,650 |
| China | $310,000 | — | $270,000 | $629,964 | $2,098,128 | $77,400 |
| Domestic | — | — | $5,361,880 | $3,289,872 | $3,571,549 | $2,120,186 |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Handpieces | $7,137,757 | $6,974,648 | $7,156,632 | $6,450,876 | $8,026,884 |
| Instruments | $1,761,463 | $1,565,159 | $2,550,051 | $2,215,740 | $2,159,910 |
| Other | $74,762 | $90,121 | — | — | — |
| Accessories | — | — | $120,761 | $139,290 | $117,917 |
Segment Operating Income
Annual operating income by business segment, as tagged in the company's own XBRL filings. Segments need not sum to the consolidated figure — corporate costs and eliminations are typically unallocated.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dental | $1,923,265 | $1,574,242 | — | — | — | — |
| Medical | -$1,431,873 | -$2,055,950 | — | — | — | — |
| Dental Segment | — | $1,576,042 | $2,080,604 | $1,121,815 | $2,475,059 | $817,355 |
| Medical Segment | — | -$2,057,750 | -$3,708,171 | -$4,788,105 | -$4,105,854 | -$3,338,411 |
Operating Margin by Segment (%)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Dental | 21.9% | 18.5% | — | — | — | — |
| Medical | -781.4% | -1965.2% | — | — | — | — |
| Dental Segment | — | — | 21.3% | 12.8% | 24.4% | 15.1% |
| Medical Segment | — | — | -5618.4% | -9077% | -2697.7% | -21129.2% |